{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:45:45Z","timestamp":1782981945683,"version":"3.54.5"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Peristomal pyoderma gangrenosum (PPG) is a non-infectious neutrophilic dermatosis most commonly seen in the context of ostomies in inflammatory bowel disease. The lack of established treatment guidelines and high-quality evidence in the form of randomized controlled trials present a major challenge in PPG management, owing to the rarity of the condition. Treatment can be further complicated by difficulties in maintaining the stoma pouch seal with conventional topical corticosteroids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CASE:<\/jats:title>\n            <jats:p>We present a case of PPG treated with aerosol steroid inhaler, highlighting the need for innovative solutions in the management of the condition to maintain the stoma pouch seal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>We achieved rapid and sustained resolution with the aerosol steroid, thus sparing the need for systemic agents, and we would like to advocate for its licensed use in PPG.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/won.0000000000001150","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T16:01:15Z","timestamp":1737648075000},"page":"81-83","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Rapid and Sustained Resolution of Peristomal Pyoderma Gangrenosum With Aerosol Steroid Treatment"],"prefix":"10.1097","volume":"52","author":[{"given":"Kyriaki Stefania","family":"Mitsaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindi","family":"Gaglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieran","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"6","key":"R1-20250127","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jaad.2017.12.049","article-title":"Diagnosis and management of peristomal pyoderma gangrenosum: a systematic review","volume":"78","author":"Afifi","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"R3-20250127","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"R4-20250127","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7861\/clinmedicine.19-3-224","article-title":"Pyoderma gangrenosum \u2013 a guide to diagnosis and management","volume":"19","author":"George","year":"2019","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"R5-20250127","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jid.2020.04.019","article-title":"Comparison of three diagnostic frameworks for pyoderma gangrenosum","volume":"141","author":"Haag","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"18","key":"R6-20250127","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa013383","article-title":"Skin ulcers misdiagnosed as pyoderma gangrenosum","volume":"347","author":"Weenig","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"R7-20250127","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1523-1747.1998.00311.x","article-title":"Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum","volume":"111","author":"Adachi","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"9","key":"R8-20250127","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/BF02052602","article-title":"Parastomal pyoderma gangrenosum in inflammatory bowel disease","volume":"37","author":"Tjandra","year":"1994","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"R9-20250127","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2230.2009.03413.x","article-title":"Beclometasone inhaler used to treat pyoderma gangrenosum","volume":"35","author":"Chriba","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"R10-20250127","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ijscr.2014.11.015","article-title":"Aerosol steroids for the treatment of peristomal mucocutaneous breakdown due to severe eczema","volume":"5","author":"Nicholson","year":"2014","journal-title":"Int J Surg Case Rep"}],"container-title":["Journal of Wound, Ostomy &amp; Continence Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WON.0000000000001150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T14:00:14Z","timestamp":1737986414000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/WON.0000000000001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/won.0000000000001150","relation":{},"ISSN":["1071-5754","1528-3976"],"issn-type":[{"value":"1071-5754","type":"print"},{"value":"1528-3976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}